Federal antitrust trial attorney Anna Neill focuses on bringing claims for large retail pharmacy chains against brand and generic pharmaceutical companies that engage in anticompetitive practices designed to thwart generic competition and drive up prescription drug costs.
She has represented retailer plaintiffs in well over a dozen pharmaceutical reverse-payment/“pay-for-delay” cases, pursuing brand drug manufacturers and their potential generic drug competitors who enter into “pay-for-delay” conspiracies to postpone the introduction of a competing generic drug.
Anna was a member of the Miami Chapter of the ACLU of Florida from 2016 until 2023, serving as a member of the chapter’s legal panel and as chapter secretary from 2021 through 2023. She also has served as a vice-chair of the Health Care & Pharmaceuticals Committee of the Antitrust Section of the ABA since 2022.
Anna has an active pro bono practice. Currently, she is representing authors and schoolchildren in federal litigation against certain school boards in Florida in cases alleging First Amendment violations related to those boards’ removal of children’s book And Tango Makes Three from school libraries based on its positive LGBTQ+ viewpoint. She also previously worked as a cooperating attorney with the ACLU in federal litigation to protect the rights of individuals experiencing homelessness.
Before joining the firm, she worked for a large, international law firm primarily practicing intellectual property litigation.
Honors & Awards
- Chambers USA, Band 2, Antitrust, 2024
- Best Lawyers in America, 2021-present
- Commercial Litigation
Representative Cases
Represented retailer plaintiffs in In re Modafinil Litigation, Case No. 06-cv-02768-MSG (E.D. Pa.), a suit against several brand and generic pharmaceutical manufacturers that alleged that those manufacturers entered into a pay-for-delay scheme to delay competition for the branded drug Provigil. Anna was part of the trial team that pursued a 16-day jury trial against a generic manufacturer defendant in the Eastern District of Pennsylvania before the case settled.
Represented retailer plaintiffs in the multidistrict litigation In re Solodyn (Minocycline hydrochloride) Antitrust Litigation, 14-md-02503-DJC (D. Mass.), a case alleging an unlawful agreement between a brand and generic pharmaceutical companies that resulted in the delay of generic Solodyn to the market. Anna was part of the team that tried the case to a jury before reaching a settlement at the close of the plaintiffs’ case.
Represented retailer plaintiffs in In re Glumetza Antitrust Litigation, 19-cv-05822-WHA (N.D. Cal.), a suit alleging that various brand and generic drug manufacturers entered into an unlawful agreement to delay the introduction of generic competitors to the type-2 diabetes drug Glumetza. The case settled before trial after plaintiffs prevailed against defendants’ summary judgment motions attacking the presence of an antitrust violation and causation.
Represented the plaintiff class of individuals experiencing homelessness in Miami in Pottinger v. City of Miami (now known as Peery v. City of Miami, Case No. 19-cv-10957) against the City of Miami in an attempt to enforce the Pottinger consent decree and hold the City in contempt for violating the decree through a series of sweeps banishing homeless persons from encampments and destroying their IDs, medicine, clothes, and other essential belongings.
Newsroom
News & Events
August 19, 2021 - 17 Kenny Nachwalter Attorneys Recognized in the Best Lawyers In America© 2022
August 20, 2020 - 15 Kenny Nachwalter Attorneys Recognized In The Best Lawyers In America© 2021, Two Selected “Lawyer Of The Year”
Speaking Engagements
Faculty, “Pleading and Proving Conspiracy,” ABA Antitrust Masters Course, 2024
Panelist, “Non-Price Abuses: A New Frontier in Pharma?” ABA Health Care and Pharmaceuticals Committee Webinar, 2023
Faculty, “Pleading and Proving Conspiracy,” ABA Antitrust Masters Course, 2022
Faculty, “Expert Witnesses,” ABA Antitrust Masters Course, 2022
Moderator, “Civil Liberties and LGBTQ+ Rights in Florida,” ALCU of Florida Greater Miami Chapter Forum, 2021
Panelist, “In re: Solodyn Antitrust Litigation: Lessons from a ‘Big Stakes’ Reverse Payment Pharmaceutical Trial,” Golden State Antitrust, UCL and Privacy Law Institute, 2018
Professional Activities
Professional Memberships
ACLU of Florida Greater, Miami Chapter, 2016 - 2023
- Legal Panel Member, 2016 - 2023
- Board Member, 2017 - 2023
- Secretary of the Board, 2021 - 2023
American Bar Association
- Antitrust Law Section
- Vice Chair, Health Care and Pharmaceuticals Committee, 2022-present
- Litigation Section
California Lawyers Association
- Antitrust and Unfair Competition Law Section
- Intellectual Property Law Section
The Florida Bar
- Business Law Section
- Trial Lawyers Section
Practice Areas
Clerkships
- Law Clerk, Hon. Rosemary Barkett of the U.S. Court of Appeals for the Eleventh Circuit, 2008-2009
Education
J.D., Stanford Law School, 2008
Ph.D., Scripps Institution of Oceanography, University of California, San Diego
- Marine Biology, 2005
B.A. and B.S., University of Richmond, summa cum laude, 1999
- Phi Beta Kappa
Bar Admissions
- Florida
- California
- U.S. Supreme Court
- U.S. Court of Appeals, First Circuit
- U.S. Court of Appeals, Third Circuit
- U.S. Court of Appeals, Ninth Circuit
- U.S. Court of Appeals, Eleventh Circuit
- U.S. District Court, Central District of California
- U.S. District Court, Northern District of California
- U.S. District Court, Middle District of Florida
- U.S. District Court, Southern District of Florida
- U.S. District Court for the Northern District of Florida
